about
Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouseRegulatable systems: applications in gene therapy and replicating viruses.An episomal vector for stable tetracycline-regulated gene expressionGeneration of conditional mutants in higher eukaryotes by switching between the expression of two genesGeneration of a tamoxifen inducible Tnnt2MerCreMer knock-in mouse model for cardiac studiesThe evolution of heart gene delivery vectorsRegulated expression of foreign genes in vivo after germline transfer.Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy.Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypesCreation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus.Diverse strategies for tetracycline-regulated inducible gene expression.Bi-directional gene switching with the tetracycline repressor and a novel tetracycline antagonistSelf-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells.Evaluation of the tetracycline- and ecdysone-inducible systems for expression of neurotransmitter receptors in mammalian cells.An improved system for estradiol-dependent regulation of gene expression in yeast.Inducible and selective transgene expression in murine vascular endothelium.Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy.Adeno-retroviral chimeric viruses as in vivo transducing agents.
P2860
Q30427066-262E1ACC-B78D-46DB-8E82-FACC088053E6Q33590571-A7CABA7E-34A5-4D9F-8A6B-10DFA4BE351BQ33904282-BD2658B5-2ED9-417F-8F37-C4B7F115D6ECQ34632572-0377F59D-BB72-4592-93CD-7937DDC60ED7Q34947822-7CDF4182-9972-484F-BBAE-9AB1EA6DE0F5Q35779565-62E6D73B-79A4-4D13-81B6-B4D39CE9E91BQ35799722-D2E8DAFB-C588-42BA-9DCC-E5DC565B443EQ35824617-07C25023-816C-42E3-A521-8A1EECCABA36Q36365860-1EA8AE7C-0675-43B4-8F86-1E53D6DF3ED7Q36565055-34CD07E6-64C3-4D21-A2BD-7D51DBEFC3BDQ37369799-DC5D2B55-A831-499B-80ED-02B2CAD847A8Q37374777-C9CAE424-D8A7-4D8C-96E5-9EA34EAB9B15Q37506166-FE5FDF3D-5EA3-4AB8-88CE-C84BDB17FE03Q37579022-B65BAA79-D222-4A49-84F6-BEFD44789144Q39716998-E364C4CD-6BB5-4027-BA5D-8010885584EEQ39872945-45D60471-F1FE-4C6C-AD6E-1005DEA5DF22Q40775660-6BB4EE7D-2763-4D06-B681-7B09DB7AA8C1Q42183539-CEB33E9C-C8F1-42D7-AB0E-E5574ED66DEEQ42527108-B6E0D3A0-0BC2-4F73-8D84-8997323A6F40Q43767321-757630B2-9AA2-4F69-AAD9-DA8971AE0587Q44121800-F1979CD9-4FA8-4C81-B9C6-55AF2A930D37
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Tetracycline-regulated cardiac gene expression in vivo.
@ast
Tetracycline-regulated cardiac gene expression in vivo.
@en
Tetracycline-regulated cardiac gene expression in vivo.
@nl
type
label
Tetracycline-regulated cardiac gene expression in vivo.
@ast
Tetracycline-regulated cardiac gene expression in vivo.
@en
Tetracycline-regulated cardiac gene expression in vivo.
@nl
prefLabel
Tetracycline-regulated cardiac gene expression in vivo.
@ast
Tetracycline-regulated cardiac gene expression in vivo.
@en
Tetracycline-regulated cardiac gene expression in vivo.
@nl
P2860
P356
P1476
Tetracycline-regulated cardiac gene expression in vivo
@en
P2093
M L Kaplan
P M Buttrick
P2860
P304
P356
10.1172/JCI117174
P407
P577
1994-04-01T00:00:00Z